6
Y. Otsuka et al.
3S structure and (−)-epicatechin is a 2R, 3R structure
indicating that C-4 carbonylation by OX-01 is specific to
the 2R-stereoisomer.
observation of potential relevance to the progression of
Alzheimer’s disease. These and others reports suggest
that (+)-taxifolin will continue to be a compound of
significant pharmaceutical interest. If we can utilize the
enzyme function of OX-01 effectively, (+)-taxifolin
could be produced from (+)-catechin and/or (−)-epicat-
echin, both of which are abundant plant flavonoids and
easily recovered by simple extraction. Therefore, we
believe this study will contribute not only to a better
understanding of microbial degradation of catechin in
forest ecosystems, but will also provide insights into
processes which may enable the economically favorable
production of (+)-taxifolin for commercial use.
The 1H NMR spectrum of reaction products trans-
formed from (−)-epicatechin was consistent with the
spectrum of (+)-taxifolin and not (−)-epitaxifolin. This
result indicates that the isomerization occurs at C-3
position. (Figure 4) shows the proposed conversion
pathway of (+)-catechin and/or (−)-epicatechin into
(+)-taxifolin in the presence of a cellular extract of
OX-01. This crude OX-01 extract not only converted
(+)-catechin to (+)-taxifolin but also was capable
of converting (−)-epicatechin to (+)-taxifolin. The
(−)-epicatechin was converted to (−)-epitaxifolin via a
2,3-cis-leucocyanidin
intermediate
because
the
Author contributions
stereoisomers at the C-3 position were stable when the
2,3-cis-leucocyanidin was formed.18) The (−)-epitaxi-
folin converged with (+)-taxifolin as a more stable
structure via compound A through a non-enzymatic
keto–enol tautomeric reaction.
Yuichiro Otsuka, Motoki Matsuda, Tomonori Sonoki,
Kanna Sato-Izawa, Barry Goodell, Jody Jelison, Hitoshi
Murata, and Masaya Nakamura designed this study.
Yuichiro Otsuka, Motoki Matsuda, and Hitoshi Murata
performed the experiment. Yuichiro Otsuka, Motoki
Matsuda, Barry Goodell, Jody Jellison, and Ronald R.
Navarro wrote this manuscript. All the authors
reviewed and approved the manuscript.
In aerobic bacteria, (−)-epicatechin metabolism has
not been reported. Almost all of the flavanols in free
form in the leaves, such as tea leaves, have been found
to be in the (+)-catechin (2R, 3S) structure. However,
flavanol units observed in bark as condensed tannins
were of the (+)-catechin and (−)-epicatechin (2R, 3R)
structure.19) In our work, (−)-catechin and (+)-epicate-
chin were unable to react with the crude OX-01 extract,
but it should be noted that these forms are rare in nat-
ure. There are however, some bacterium that can
degrade (−)-catechin. Wang et al.20) reported that a bac-
terium isolated from the rhizosphere of the (−)-cate-
chin-producing plant, Rhododendron formosanum,
could degrade (−)-catechin and was capable of using
(−)-catechin as a sole carbon source. The catechin
oxidative enzymes of OX-01, which lack the ability to
react with the (−)-catechin, may have a different evolu-
tionary origin and ecological function from that of the
(−)-catechin-degrading bacteria described by Wang.
Jeremy et al.21) reported that procyanidin oligomers,
constructed of catechin units, automatically decom-
posed to catechin monomers under acidic conditions. In
acidic forest soil containing leaf litter and various other
plant constituents, part of the condensed tannin also
would be automatically decomposed to catechins. This
suggests that the evolutionary targets for the OX-01
catechin oxidative enzymes were not only (+)-catechin
in leaves and nutshells as a free form, but also the
more recalcitrant (−)-epicatechins present in bark as a
condensed tannin polymer. A more detailed analysis of
the catechin degradation abilities in OX-01 will con-
tribute to the understanding of how flavonoids and con-
densed tannins, produced in great quantities by plants
are recycled by soil micro-organisms under acidic con-
ditions.
Disclosure statement
No potential conflict of interest was reported by the authors.
Funding
This work was supported by the Grant-in-Aid for Young Scientists
(B) of KAKENHI [grant number 19880035]; [grant number
21780169].
References
[1] Hemingway RW, Laks PE, Branham SJ. Plant polyphenols: syn-
thesis, properties, significance. Heidelberg: Springer; 1992.
[2] Eberhardt TL, Young RA. Conifer seed cone proanthocyanidin
polymers: characterization by 13C NMR spectroscopy and deter-
mination of antifungal activities. J. Agric. Food Chem.
1994;42:1704–1708.
[3] Shaw LJ, Morris P, Hooker JE. Perception and modification of
plant flavonoid signals by rhizosphere microorganisms. Environ.
Microbiol. 2006;8:1867–1880.
[4] Otsuka Y, Muramatsu Y, Nakagawa Y, et al. Burkholdria oxy-
phila sp. nov., a bacterium isolated from acidic forest soil that
catabolizes (+)-catechin and its putative aromatic derivatives. Int.
J. Syst. Evol. Microbial. 2011;61:249–254.
[5] Matsuda M, Otsuka Y, Jin S, et al. Biotransformation of (+)-cat-
echin into taxifolin by a two-step oxidation: primary stage of
(+)-catechin metabolism by a novel (+)-catechin-degrading bacte-
ria, Burkholderia sp. KTC-1, isolated from tropical peat. Bio-
chem. Biophys. Res. Commun. 2008;366:414–419.
[6] Bauchop T, Elsden SR. The growth of micro-organisms in relation
to their energy supply. J. Gen. Microbiol. 1960; 23: 457–469.
[7] Jeffrey AM, Jerina DM, Self R, et al. The bacterial degradation
of flavonoids. Oxidative fission of the A-ring of dihydro-
gossypetin by a Pseudomonas sp. Biochem. J. 1972;130:383–
390.
[8] Jeffrey AM, Knight M, Evans WC. The bacterial degradation of
flavonoids. Hydroxylation of the A-ring of taxifolin by a soil
pseudomonad. Biochem. J. 1972;130:373–381.
The (+)-taxifolin is not only of ecological interest
but is also of proven and potential medical interest.
This compound is not mutagenic and less toxic than
the similar flavonoid quercetin.22) Numerous reports on
(+)-taxifolin demonstrate its many medicinal applica-
23)
tions including anti-cancer
and antioxidant activ-
ity.24) In addition, Sato et al.25) recently reported that
(+)-taxifolin could inhibit amyloid β aggregations, an